Showing 9601-9610 of 18069 results for "".
- Pediatric Food Allergy Treatment with Multi-Food Immunotherapyhttps://reachmd.com/news/food-allergy-management-multi-food-immunotherapy-in-pediatric-care/2474621/Multi-food immunotherapy is emerging as a transformative approach in managing food allergies in children. Utilizing a methodical, gradual exposure to different allergens, this technique cultivates tolerance in pediatric patients—a significant breakthrough that is r
- Breastfeeding Data Monitoring: Real-Time Insights into Milk Consumptionhttps://reachmd.com/news/breastfeeding-data-monitoring-real-time-insights-into-milk-consumption/2474672/In a significant stride for neonatal care and parental support, a new real-time breastfeeding monitoring device is transforming how clinicians and parents assess infant nutrition. Designed to provide precise, continuous insights into milk intake, the device offers a
- Johnson & Johnson MedTech Launches Larger-Sized Breast Implants for Post-Mastectomy Reconstructionhttps://reachmd.com/news/johnson-johnson-medtech-launches-larger-sized-breast-implants-for-post-mastectomy-reconstruction/2475365/Johnson & Johnson MedTech has announced the U.S. launch of MENTORTM Memory GelTM Enhanced Breast Implants, a new line of breast implants specifically developed for women undergoing primary or revision reconstruction after mastectomy. The implants, which received FDA appr
- Dietary Strategies: Addressing Psoriasis Through Nutritional Interventionshttps://reachmd.com/news/dietary-strategies-addressing-psoriasis-through-nutritional-interventions/2474645/Psoriasis poses a significant challenge within its complex management framework. Emerging studies indicate that dietary modifications notably affect inflammatory processes and symptom severity, presenting a promising complement to standard treatments.
- Chronic Illness and Depression: Assessing Risk in Comorbid Conditionshttps://reachmd.com/news/chronic-illness-and-depression-assessing-risk-in-comorbid-conditions/2474603/In the quiet spaces between routine medical checkups and ongoing medication refills, a more insidious burden often lingers—one that doesn’t show up on blood tests or imaging scans. For patients managing multiple chronic illnesses, the weight isn’t just physiologica
- Feeding Immunity: How Maternal Nutrition Shapes Childhood Allergy Riskhttps://reachmd.com/news/maternal-diet-and-child-food-allergy-outcomes/2474616/The medical community is increasingly examining how maternal diet during pregnancy and breastfeeding affects the development of food allergies in children. This article explores the latest research, emphasizing the critical role of nutrition during these pivotal de
- Childhood Obesity and Its Role in Adult Weight Stigmahttps://reachmd.com/news/childhood-obesity-and-its-role-in-adult-weight-stigma/2474575/A growing body of research is illuminating the often-overlooked social legacy of early-onset obesity: enduring weight stigma that follows individuals well into adulthood.
- Bioinformatics Illuminate Biomarkers in Anaplastic Thyroid Cancerhttps://reachmd.com/news/anaplastic-thyroid-cancer-differential-gene-expression-as-potential-biomarkers/2474601/In addressing anaplastic thyroid cancer (ATC), advanced bioinformatic strategies are illuminating unique patterns of gene expression that hold potential as critical biomarkers, transforming diagnostic and therapeutic paradigms.
- HER3 and Cancer Progression: Investigating Mechanisms of Therapy Resistancehttps://reachmd.com/news/her3-and-cancer-progression-investigating-mechanisms-of-therapy-resistance/2474612/The rediscovery of HER3 as a crucial player in cancer progression has transformed our understanding of tumor biology. Previously eclipsed by other ErbB receptors, HER3 is recognized for its intricate signaling networks that spur therapy resistance and foster cell s
- Pentoxifylline and Its Limitations in Severe Alcohol-Associated Hepatitishttps://reachmd.com/news/pentoxifylline-and-its-limitations-in-severe-alcohol-associated-hepatitis/2474606/Robust clinical trials and real-world data consistently indicate that pentoxifylline fails to improve survival in patients with severe alcohol-associated hepatitis. This evidence necessitates reevaluating its use as a treatment to decre